Journal
OPEN FORUM INFECTIOUS DISEASES
Volume 7, Issue 11, Pages -Publisher
OXFORD UNIV PRESS INC
DOI: 10.1093/ofid/ofaa505
Keywords
antibody response; humoral immunity; measles; mumps; rubella; seroprotection; vaccine; waning
Categories
Funding
- Dutch Ministry of Health, Welfare and Sport
Ask authors/readers for more resources
Background. Breakthrough infections of measles and mumps have raised concerns about the duration of vaccine-induced immunity, which might be improved by a third dose of measles-mumps-rubella vaccine (MMR3). Methods. Here we compared (IgG) antibody levels against measles, mumps, and rubella in blood samples of 9-year-old children and young adults (18-25 years) following MMR2 and MMR3, respectively. Results. We found that, in addition to antibody boosting for all 3 vaccine components, MMR3 resulted in lower antibody decay rates than MMR2; the declines were most prominent for mumps and rubella. Conclusions. This study suggests that MMR3 provides long-lasting seroprotection against measles, mumps, and rubella.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available